reported that GPER over-expression and plasma membrane localization are key drivers of BC progression, with high membrane GPER correlating with poor histological grade, while its absence predicts excellent long-term prognosis in ER-positive tamoxifen-treated patients (296). Here, ESR1 is linked to breast cancer.